High materiality7/10
Protagonist Therapeutics price target raised to $170 from $145 at Truist
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
PTGX PT raised to $170; current price $148.45; Analyst: Srikripa Devarakonda (Truist).
- PTGX: PT $170; price $148.45; Truist.
Key facts
- 01
Target: $170
- 02
Posted price: $148.45
- 03
Analyst firm: Truist Financial
- 04
Analyst: Srikripa Devarakonda
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.